Jade Biosciences - Enters Exclusive Worldwide License Agreement With Paragon Therapeutics - SEC Filing

Jade Biosciences Inc NASDAQ:JBIO:

• JADE BIOSCIENCES - ENTERS EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH PARAGON THERAPEUTICS - SEC FILING

• JADE BIOSCIENCES - TO PAY UP TO $22 MILLION IN MILESTONE PAYMENTS TO PARAGON - SEC FILING

• JADE BIOSCIENCES - TO PAY PARAGON LOW TO MID-SINGLE-DIGIT PERCENTAGE ROYALTIES ON NET SALES OF LICENSED PRODUCTS - SEC FILING

• JADE BIOSCIENCES - PARAGON BARRED FROM NEW CAMPAIGNS TARGETING LICENSED TARGET FOR AT LEAST FIVE YEARS - SEC FILING